hit counter

Personalized Care for Young-Onset Diabetes Eased Distress, Not Complications

MHD card showing a DNA helix that turns into a glucose curve flowing into a clinician's tablet with a personalized report, illustrating the PRISM trial in which personalized care for young-onset diabetes eased diabetes distress but did not reduce complications.

Adults in Hong Kong who developed diabetes by age 40 reported less diabetes distress after a year of personalized care that included genetic and biomarker testing. Over 3 years, though, the extra care did not lower their rate of diabetes complications.1 Research Highlights A large randomized trial: the PRISM trial assigned 884 Chinese adults with …

Read more